ConductScience.org, home

Paper35537409

IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.

Delyon J and 1 other. Cancer Cell, 2022. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy. Papers, record 35537409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35537409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy.
PubMed
Journal
Cancer Cell
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Comment
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2022-07-19
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Delyon JJulie
2Lebbe CCeleste

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immune Checkpoint InhibitorsMajor topic
NeoplasmsMajor topic
CTLA-4 Antigen
Humans
Immunotherapy
Interleukin-6
Programmed Cell Death 1 Receptor

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on35537412Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.https://conductscience.org/library/papers/35537412

Source PubMed

Download CSV of comments and corrections

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42941734Genetic and Immunologic Interactions Driving STAT3 Signaling and Macrophage Polarization in Acute Myeloid Leukemia.Int J Mol Sci2026https://conductscience.org/library/papers/42941734PubMed
42233032Research landscape, thematic evolution, and translational insights of immune checkpoint inhibitor-induced colitis: a bibliometric analysis (2006-2025).Front Immunol2026https://conductscience.org/library/papers/42233032PubMed
41897336The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities.Biomolecules2026https://conductscience.org/library/papers/41897336PubMed
41461940An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments.Nat Nanotechnol2026https://conductscience.org/library/papers/41461940PubMed
41310062Immunological factors underlying radiation-induced toxicity in prostate cancer patients: a systematic review.Discov Oncol2025https://conductscience.org/library/papers/41310062PubMed
40699636Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell Growth.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699636PubMed
39981232Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.Front Immunol2025https://conductscience.org/library/papers/39981232PubMed
39928524Nanoenhanced-Cuproptosis Results From the Synergy of Calcium Overload and GSH Depletion with the Increasing of Intracellular Ca/Mn/Cu Ions.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39928524PubMed
39837814Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39837814PubMed
39523982Tocilizumab for Advanced Non-Small-Cell Lung Cancer With Concomitant Cachexia: An Observational Study.J Cachexia Sarcopenia Muscle2024https://conductscience.org/library/papers/39523982PubMed
39256296Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review.Cardiovasc Toxicol2024https://conductscience.org/library/papers/39256296PubMed
39015563Advancing non-small cell lung cancer treatment: the power of combination immunotherapies.Front Immunol2024https://conductscience.org/library/papers/39015563PubMed
38689325Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.J Transl Med2024https://conductscience.org/library/papers/38689325PubMed
38443899Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.J Transl Med2024https://conductscience.org/library/papers/38443899PubMed
38044322Combining immune-checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre-existing polymyalgia rheumatica: A case report.Thorac Cancer2024https://conductscience.org/library/papers/38044322PubMed
37208766Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy.Cell Commun Signal2023https://conductscience.org/library/papers/37208766PubMed
36539321Treatment of rheumatic adverse events of cancer immunotherapy.Best Pract Res Clin Rheumatol2022https://conductscience.org/library/papers/36539321PubMed
36198831Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases.Nat Rev Rheumatol2022https://conductscience.org/library/papers/36198831PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35537409

GET https://conductscience.org/api/papers/v1/35537409/authors